Kyorin University Venture Firm To Start Pancreatic Cancer Trial
This article was originally published in PharmAsia News
Executive Summary
Tokyo-based Kyorin University venture firm J Pharma will start clinical trials for JPH203, a drug candidate targeting patients with gastric and pancreatic cancer